About us
The Beghou difference
Read more ->
What we stand for
Beghou helps innovative businesses and analytical minds like yours thrive
Our people
Our senior leaders are true partners - deeply involved, long-tenured, and always accountable
ESG commitments
We’re passionate about driving positive change in life sciences and for the rest of the world
Problems we solve
Commercial excellence
Empower and align high-performing teams
Customer experience
Anticipate provider needs, engage the right way
Patient engagement
Identify and support the right patients sooner
Value and access
Bridge clinical value and payer priorities
Data enablement
Create a unified, adaptive data foundation
AI that works
Embed AI in everyday workflows
Our solutions
The Beghou Arc Platform
The modern commercialization platform
Explore the platform ->
Our solutions
Solutions for life sciences commercialization ->
Commercial operations
Forecasting
Customer engagement optimization
Omnichannel
Patient solutions
Value and access
Digital health
Data management
AI and advanced analytics
Market research
Our resources
Careers
Life at Beghou
Be you and build your life sciences career at Beghou
Jobs at Beghou
Join a collaborative team driving patient impact and operational excellence
Contact our experts
Articles by
Marc Iskowitz
FAST 5
Obesity pill launches show Lilly, Novo plugging operational gaps
Apr 10 2026
FAST 5
Patients are reshaping the health information journey
Mar 29 2026
FAST 5
J&J’s new psoriasis pill to challenge older biologics
Mar 23 2026
FAST 5
Could an FDA official’s exit spell regulatory relief for biotech?
Mar 20 2026
The Beghou Biopharma Review
Rep, regulatory shifts quicken pharma’s commercial evolution
Mar 19 2026
The Beghou Biopharma Review
Closing out 2025: AI's big leap and the search for organizational harmony
Mar 19 2026
The Beghou Biopharma Review
Dealing with dual demands: Tariffs, price caps create competing pressures for pharma marketers
Mar 19 2026
The Beghou Biopharma Review
From trade tensions to therapy pivots: What’s shaping pharma this summer
Mar 19 2026
The Beghou Biopharma Review
Launch radar: What 2026’s drug launches signal to commercial leaders; 4 questions for AbbVie’s Brent Hasko
Mar 19 2026
Article
Building a vendor strategy: Protecting commercial plans from supplier-driven data risk
Mar 10 2026
How to keep reps happy and compensated amidst pharma’s growing direct-to-consumer sales models
Aug 29 2025
Article
How pharma marketers can prepare for Trump’s 200% tariff threat
Jul 16 2025
What ASCO2025's exhibit hall says about biopharma’s shifting oncology agenda
Jun 19 2025
What Databricks’ latest deal means for pharma’s AI aspirations
May 31 2025
